Arkolith/Insider Trading/TMCI/Form 4

Treace John T.

Chief Executive Officer, Director, 10% OwnerTREACE MEDICAL CONCEPTS, INC. (TMCI) · full profile →Form 4 · filed Jun 11, 2024
Net Buying
Open-Market Buys
$265K
Open-Market Sells
$0
Net Open-Market Flow
$265K
Transactions
1
1 non-derivative · 0 derivative

Non-Derivative Transactions (Table I)

DateActionSharesPriceValueOwned After
Jun 11, 2024Buy(P)45K$5.88$265K6.4M

Transaction Codes

P
Open-market purchase

Data Source & Provenance

Parsed from a single SEC EDGAR Form 4 filing (accession 0000950170-24-072078) within minutes of acceptance. Every field above traces to the original document. Verify it directly:

View original filing on SEC.govRaw Form 4 XML